BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu K, Bao JF, Wang T, Yang H, Xu BP. Camrelizumab-induced anaphylactic shock in an esophageal squamous cell carcinoma patient: A case report and review of literature. World J Clin Cases 2022; 10(18): 6198-6204 [PMID: 35949858 DOI: 10.12998/wjcc.v10.i18.6198]
URL: https://www.wjgnet.com/2307-8960/full/v10/i18/6198.htm
Number Citing Articles
1
Man Sun, Huan Zhou, Dan Zang, Chen-Guang Liu, Jun Chen. Camrelizumab-induced immune-related toxic epidermal necrolysis in lung adenocarcinoma: a case report and literature reviewFrontiers in Oncology 2025; 14 doi: 10.3389/fonc.2024.1417936
2
CamrelizumabReactions Weekly 2022; 1916(1): 121 doi: 10.1007/s40278-022-19580-7
3
Jiarui Hu, Jieting Fan, Shaobo Qu, Xiaohua He, Daiwei Liu, Yongxia Wang, Xiaoyuan Wu, Zhanlin Li. Camrelizumab-induced anaphylactic reaction: a case report and literature reviewJournal of Chemotherapy 2024; : 1 doi: 10.1080/1120009X.2024.2372525
4
Li Song, Yan Liang, Yilin Li, Tingting Guo, Hui Li, Shuxuan Liang. Development of an LC–TOF/MS Method to Quantify Camrelizumab in Human SerumMolecules 2024; 29(20): 4862 doi: 10.3390/molecules29204862